AI to quantify senescent cell counts
A long-awaited AI approach can now be implemented in screening for anti-senescence drug candidates.
Developing a...
Senolytic start-up gears up for clinical trials
Rubedo’s first target is respiratory disease, with COVID-19 expected to drive an increase in lung...
Predicting Longevity using polygenic risk scores
Health and disease prediction scores could become a routine personal genomics risk prediction method for...
Gerostate Alpha: “Our phenotype is lifespan”
Buck Institute start-up's founders talk drug discovery, indications and raising funding.
Following yesterday's introduction to Gerostate...
CohBar announces preclinical collaboration with NIAID
CohBar and NIAID set to assess CB5064 Analogues for COVID-19 and respiratory distress treatment.
Clinical stage...